Pharmaniaga Berhad (KLSE: PHARMA)
Malaysia
· Delayed Price · Currency is MYR 0.380
-0.005 (-1.30%)
At close: Oct 11, 2024
Pharmaniaga Berhad Ratios and Metrics
Market cap in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 548 | 555 | 714 | 969 | 1,309 | 538 | Upgrade
|
| Market Cap Growth | 10.00% | -22.28% | -26.35% | -25.92% | 143.16% | -25.69% | Upgrade
|
| Enterprise Value | 1,715 | 1,690 | 1,800 | 1,749 | 2,023 | 1,242 | Upgrade
|
| Last Close Price | 0.38 | 0.39 | 0.55 | 0.67 | 0.87 | 0.35 | Upgrade
|
| PE Ratio | - | -6.57 | -1.13 | 5.13 | 41.23 | -3.02 | Upgrade
|
| PS Ratio | 0.16 | 0.16 | 0.21 | 0.20 | 0.48 | 0.19 | Upgrade
|
| PB Ratio | -2.16 | -2.02 | -2.05 | 2.06 | 3.69 | 1.51 | Upgrade
|
| P/FCF Ratio | -4.81 | -149.12 | -3.54 | -10.26 | -37.43 | 3.18 | Upgrade
|
| P/OCF Ratio | -8.90 | 11.82 | -5.02 | -15.13 | -50.90 | 2.84 | Upgrade
|
| EV/Sales Ratio | 0.49 | 0.50 | 0.52 | 0.36 | 0.74 | 0.44 | Upgrade
|
| EV/EBITDA Ratio | 34.89 | 229.97 | 32.36 | 5.22 | 21.42 | 10.00 | Upgrade
|
| EV/EBIT Ratio | 146.95 | -82.65 | 64.27 | 5.69 | 29.93 | 13.35 | Upgrade
|
| EV/FCF Ratio | -15.48 | -454.13 | -8.93 | -18.52 | -57.86 | 7.33 | Upgrade
|
| Debt / Equity Ratio | -4.89 | -4.35 | -3.35 | 1.82 | 1.89 | 1.59 | Upgrade
|
| Debt / EBITDA Ratio | 24.59 | 65.02 | 18.83 | 2.53 | 6.83 | 4.45 | Upgrade
|
| Debt / FCF Ratio | -10.91 | -320.18 | -5.79 | -9.07 | -19.21 | 3.36 | Upgrade
|
| Asset Turnover | 1.68 | 1.81 | 1.70 | 2.51 | 1.72 | 1.61 | Upgrade
|
| Inventory Turnover | 4.97 | 4.59 | 3.09 | 4.52 | 4.03 | 3.78 | Upgrade
|
| Quick Ratio | 0.31 | 0.24 | 0.19 | 0.22 | 0.27 | 0.25 | Upgrade
|
| Current Ratio | 0.59 | 0.55 | 0.58 | 1.10 | 0.78 | 0.78 | Upgrade
|
| Return on Equity (ROE) | - | - | -1027.82% | 41.73% | 7.38% | -33.75% | Upgrade
|
| Return on Assets (ROA) | 0.35% | -0.68% | 0.85% | 10.01% | 2.66% | 3.32% | Upgrade
|
| Return on Capital (ROIC) | 0.73% | -1.47% | 1.63% | 16.32% | 4.33% | 5.55% | Upgrade
|
| Earnings Yield | -10.34% | -14.45% | -88.23% | 17.76% | 2.10% | -27.73% | Upgrade
|
| FCF Yield | -20.23% | -0.67% | -28.24% | -9.74% | -2.67% | 31.48% | Upgrade
|
| Dividend Yield | 0.00% | - | 3.49% | 13.78% | 2.54% | 4.92% | Upgrade
|
| Payout Ratio | 0.00% | - | - | 34.24% | 95.10% | - | Upgrade
|
| Buyback Yield / Dilution | -9.39% | -4.40% | -0.05% | -0.04% | -0.33% | -0.05% | Upgrade
|
| Total Shareholder Return | -9.39% | -4.40% | 3.44% | 13.74% | 2.21% | 4.87% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.